LLY Eli Lilly: Foundayo Shows Greater Weight Loss and A1C Reduction vs. Oral Semaglutide 25 mg in Indirect Comparison ⠀ · At 52 weeks,
LLY Eli Lilly: Foundayo Shows Greater Weight Loss and A1C Reduction vs. Oral Semaglutide 25 mg in Indirect Comparison ⠀ • At 52 weeks, Foundayo 17.2 mg was associated with 1.5% greater weight loss and 0.3% greater A1C reduction. • Analysis used data from ACHIEVE-3 and PIONEER PLUS rather than a direct head-to